促销时间表 Cyclo Therapeutics, Inc.
先进的时间表
简单图表
关于公司 Cyclo Therapeutics, Inc.
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of neurodegenerative diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo that is in Phase IIb clinical trials for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. 更多详情| IPO date | 2011-02-23 |
|---|---|
| ISIN | US23254X2018 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://cyclotherapeutics.com |
| Цена ао | 1.4 |
| 每日价格变化: | +4.91% (0.57) |
|---|---|
| 每周价格变化: | -5.08% (0.63) |
| 每月价格变化: | -16.94% (0.72) |
| 3个月内价格变化: | -16.94% (0.72) |
| 六个月内的价格变化: | -50.58% (1.21) |
| 每年价格变化: | -62.39% (1.59) |
| 3年内价格变化: | -85.2% (4.04) |
| 5年内价格变化: | +99.33% (0.3) |
| 10年价格变化: | 0% (0.598) |
| 年初以来价格变化: | -14.45% (0.699) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Founders Fund V Management, LLC | 480708 | 1.67 |
| Vanguard Group Inc | 355223 | 1.24 |
| Geode Capital Management, LLC | 152077 | 0.53 |
| Founders Fund VI Management, LLC | 110023 | 0.38 |
| Citadel Advisors Llc | 54018 | 0.19 |
| Blackrock Inc. | 48444 | 0.17 |
| State Street Corporation | 39525 | 0.14 |
| Wealth Enhancement Advisory Services, LLC | 18513 | 0.06 |
| Northern Trust Corporation | 17453 | 0.06 |
| XTX Topco Ltd | 10696 | 0.04 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00344 | 17.09 | 1.54048 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. N. Scott Fine | CEO & Director | 569.92k | 1957 (68 年) |
| Mr. C. E Strattan | Founder & Director | N/A | 1946 (79 年) |
| Mr. Joshua M. Fine | CFO & Secretary | 421.17k | 1982 (43 年) |
| Mr. Michael Eric Lisjak | Senior VP of Business Development & Chief Regulatory Officer | 430.4k | 1974 (51 年) |
| Dr. Jeffrey L. Tate Ph.D. | COO, Chief Quality Officer & Director | 255.14k | 1958 (67 年) |
| Dr. Karen Mullen FFPM | Interim Chief Medical Officer | N/A | |
| Ms. Lori McKenna | Global Head of Patient Advocacy | N/A |
地址: United States, Gainesville. FL, 6714 NW 16th Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://cyclotherapeutics.com
网站: https://cyclotherapeutics.com
